Ideal Medical Technologies
Curated by SignalArtificial Intelligence based Artificial Pancreas System
Overview
Ideal Medical Technologies aims to develop an artificial intelligence based artificial pancreas for use in the ICU setting. The AI based artificial pancreas device will be a closed loop system that will require 30 minutes of daily nursing time to manage, with most of this time spent on glucose sensor (twice a day) calibration and daily replacement of the IV insulin and glucose used by the AI based system. The system uses software that adjusts the doses of IV insulin/glucose infusing into the patients on an every 5-10 minute basis, mimicking the frequency of insulin adjustment used by the native pancreas, and the frequency of glucose output from the liver. In Feb 2015, the company received US patents (US 8,956,321 B2); In April 2016, the company received European patent rights- EP2197521.
Key facts
- Founded
- 2013
- Headquarters
- Asheville, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 1 product or service
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view